Chris Hilger

CEO

SolisRx

Chris Hilger is the Founder of SolisRx, a consultancy focused on helping infusion and specialty pharmacy providers harness data analytics and AI to improve operational performance and financial outcomes. With a background spanning healthcare consulting, data science, and product development, Chris brings deep expertise in translating complex data into actionable insights that drive measurable results. He holds a Master of Science in Health Data Science from Harvard T.H. Chan School of Public Health and a Bachelor’s in Chemical Engineering from the University of Michigan. Prior to founding SolisRx, Chris worked in consulting and analytics roles across healthcare technology and provider organizations, where he focused on revenue cycle improvement, operational efficiency, and workflow optimization. He is passionate about making advanced analytics accessible and practical for mid-sized healthcare organizations. At NHIA, Chris shares practical strategies infusion operators can implement today to reduce denials and improve cash flow using simple, implementable AI models.

Sessions:

Chris Hilger is the Founder of SolisRx, a consultancy focused on helping infusion and specialty pharmacy providers harness data analytics and AI to improve operational performance and financial outcomes. With a background spanning healthcare consulting, data science, and product development, Chris brings deep expertise in translating complex data into actionable insights that drive measurable results. He holds a Master of Science in Health Data Science from Harvard T.H. Chan School of Public Health and a Bachelor’s in Chemical Engineering from the University of Michigan. Prior to founding SolisRx, Chris worked in consulting and analytics roles across healthcare technology and provider organizations, where he focused on revenue cycle improvement, operational efficiency, and workflow optimization. He is passionate about making advanced analytics accessible and practical for mid-sized healthcare organizations. At NHIA, Chris shares practical strategies infusion operators can implement today to reduce denials and improve cash flow using simple, implementable AI models.
Chris Hilger